title: Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial.
abstract: A recent analysis in the Prostate Cancer Prevention Trial (PCPT) appeared to show no association between serum lycopene and prostate cancer risk, but the unique study design of the PCPT and the complexity of prostate cancer epidemiology suggest an alternative interpretation of the reported findings.
authors.affiliation: Departments of Nutrition and Epidemiology, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02136, USA. egiovann@hsph.harvard.edu
authors.forename: Edward
authors.initials: E
authors.lastname: Giovannucci
mesh_terms: D016588:Anticarcinogenic Agents / Q000097:blood; D002277:Carcinoma / Q000097:blood / Q000473:pathology* / Q000517:prevention & control; D002338:Carotenoids / Q000097:blood*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D003627:Data Interpretation, Statistical; D018450:Disease Progression; D006801:Humans; D000077276:Lycopene; D008297:Male; D008962:Models, Theoretical; D009361:Neoplasm Invasiveness; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology* / Q000517:prevention & control
chemical_list: D016588:Anticarcinogenic Agents; D002338:Carotenoids; D000077276:Lycopene